运用组织芯片技术检测COX-2在结直肠癌中的表达及其临床意义

摘要/Abstract

摘要： 目的探讨结直肠癌组织中COX-2的表达及其与各临床病理因素的关系,评价COX-2在结直肠癌预后判断中的价值。方法应用组织芯片技术结合免疫组织化学SABC法,检测126例早中期结直肠癌组织中COX-2的表达情况,回顾性分析COX-2与各临床病理因素及预后之间的关系。结果根据免疫组化染色强度,所有病例被分为COX-2高表达组和低表达组,其中高表达组有32例(25.4%),低表达组有94例(74.6%)。COX-2在结直肠癌中表达情况与年龄、性别、肿瘤大小、肿瘤部位、组织学类型、浸润深度、淋巴是否转移、Dukes分期均无相关。然而,高表达的COX-2与肿瘤复发、特别是血行转移显著相关(P<0.05)。两组之间生存率具有显著差异(P=0.0067),COX-2高表达组术后五年生存率显著低于低表达组。多因素回归模型分析结果显示,在潜在的预后因素中(年龄、性别、肿瘤大小、肿瘤部位、组织学类型、淋巴是否转移、Dukes分期、COX-2表达),COX-2表达和Dukes分期可作为是结直肠癌根治术后独立预后因素,COX-2的检测可作为结直肠癌患者预后判断的一个有价值的指标。结论高表达的COX-2与肿瘤复发、特别是血行转移显著相关,COX-2的检测可作为结直肠癌患者预后判断的一个有价值的指标。应用组织芯片高效检测临床组织样本具有快速、方便、经济、准确的优点。

Abstract: Objective To investigate the relationship between COX-2 expression and the clinicopathological factors in colorectal carcinoma and assess the prognostic value of COX-2 detection. Methods Tissue microarray and immunohistochemistry by SABC method was employed for detecting COX-2 expression in 126 patients with advanced colorectal cancer, and the relationship of COX-2 expression with the clinicopathological features and prognosis of the patients was retrospectively analyzed. Results The patients were divided into two groups of low and high COX-2 groups according to the grade and extent of COX-2 expression. High COX-2 expression was detected in 32 (25.4%) cases, and low expression in 94 (74.6%) cases. No significant correlation was noted between COX-2 expression and the patients’ age, sex, tumor size, tumor location, histological type, lymphatic-node metastasis and Dukes’ classification, but high COX-2 expression was strongly correlated with tumor recurrence and especially with blood-borne metastasis (P<0.05). The survival rate without tumor recurrence for high-and low-COX-2 groups was assessed by the Kaplan-Meier method and compared by log-rank test, which revealed significant difference between the two groups (P=0.0067). Multivariate analysis for all patients suggested that among the 8 prognostic factors (age, sex, tumor size, tumor location, histological type, lymphatic-node metastasis, Dukes’ stage, and COX-2 expression), Dukes’ stage and COX-2 expression was the independent significant factor related to disease-free survival. Conclusion The expression of COX-2 is strongly correlated with recurrence of colorectal cancer, especially with blood-borne metastasis. COX-2 is an independent factor for prognostic evaluation of the patients, and tissue microarray allows rapid, convenient, economic and accurate COX-2 detection for large-scale application.

中图分类号:

Q78
R735.3

姚红兵¹, 吴爱国², 陈佑江¹, 唐斌华¹. 运用组织芯片技术检测COX-2在结直肠癌中的表达及其临床意义[J]. 南方医科大学学报, 2005, 25(12): 1524-1528.

YAO Hong-bing¹, WU Ai-guo², CHEN You-jiang¹, TANG Bin-hua¹. Expression of COX-2 protein in colorectal carcinoma and the clinical implication[J]. Journal of Southern Medical University, 2005, 25(12): 1524-1528.

参考文献

[1] 曹歌,沈志祥.前列腺素与结直肠肿瘤[J].世界华人消化杂志,2001,9(4):431-4.Cao G,Shen ZX.Prostaglandin and the carcinoma of colorectal[J].World J Gastroenterol,2001,9(4):431-4.
[2] Kosaka T,Miyata A,Ihara H,et al.Characterization of the hman gene (PTGS2) encoding prostaglandin-endoperoxide synthase [J].Eur J Biochem,1994,221(3):889-97.
[3] Morita I,Schindler M,Regier MK,et al.Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2 [J].J Biol Chem,1995,270(8):10902-8.
[4] Kinoshita T,Takahashi Y,Sakashita T,et al.Growth stimulation and induction of epidermal growth factor receptor by overex pression of cyclooxygenases 1 and 2 in human colon carcinoma cells [J].Biochim Biophys Acta 1999,1438(1):120-30.
[5] Hla T,Neilson K.Human cyclooxygenase-2 cDNA [J].Proc Natl Acad Sci USA,1992,89(16):7384-8.
[6] Tomozawa S,Nagawa H,Tsuno N,et al.Inhibition ofhaematogenous metastasis of colon cancer in mice by a selective COX-2inhibitor,JTE-522[J].Br J Cancer,1999,81(8):1274-79.
[7] Lynch PM.COX-2 inhibition in clinical cancer prevention [J].Oncology (Huntingt),2001,15(3 Supple 5):21-6.
[8] Gupta RA,Dubois RN.Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 [J].Nat Rev Cancer,2001,1(1):11-21.
[9] Murata H,Kawano S,Tsuji S,et al.Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma[J].Am J Gastroenterol,1999,94(2):451-5.
[10] Li G,Yang T,Yan J.Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells [J].Biochem Biophys Res Commun,2002,299(5):886-90.
[11] Sun B,Wu YL,Zhang XJ,et al.Effects of Sulindac on growth inhibition and apoptosis induction in human gastric cancer cells [J].World J Gastroenterol,2001,9(9):997-1002
[12] Wu YL,Sun B,Zhang XJ,et al.Grow th inhibition and apoptosis induction of Sulindac on Human gastric cancer cells [J].World J Gastroenterol,2001,7(7):796-800.
[13] Tsujii M,Kawano S,Tsuji S,et al.Cyclooxygenase regulates angiogenesis induced by colon cancer cells[J].Cell 1998,93(5):705-16.
[14] Cianchi F,Cortesini C,Bechi P,et al.Up-regulation of cyclooxygenase-2 gene expression correlates with tumor angiogenesis in human colorectal cancer [J].Gastroenterology,2001,121 (6):1339-47.
[15] Daniel TO,Liu H,Morrow JD,et al.Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis[J].Cancer Res,1999,59(18):4574-7.
[16] Tian G,Yu JP,Luo HS,et al.Effect ofNimesulid e on proliferation and apoptosis of human hepatoma SMMC-7721 cells [J].World J Gastroenterol,2002,8(3):483-7.
[17] Zhang JZ,Huang YW,Liu DM,et al.Tissue microarray technology and its preliminary application in large intestinal carcinoma [J].World J Gastroenterol,2002,10(2):157-60.
[18] Wu QM,Li SB,Wang Q,et al.The expression of COX-2 in esophageal carcinoma and its relation to clinicopathologic characteristic [J].World J Gastroenterol,2001,9(1):11-4.
[19] Shen ZX,Cao G,Sun J.The clinical and pathology effect of COX-2mRNA expression in colorectal cancers [J].World J Gastroenterol,2001,9(9):1082-4.
[20] Wolff H,Saukkonen K,Anttila S,et al.Expression of cyclooxygenase-2 in human lung carcinoma [J].Cancer Res 1998,58(22):4997-5001.
[21] Shiota G,Okubo M,Noumi T,et al.Cyclooxygenase-2 expression in hepatocellular carcinoma [J].Hepatogastroenterology,1999,46(25):407-12
[22] Chen WS,Wei SJ,Liu JM,et al.Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2expression and inhibited by a COX-2-selective inhibitor,etodolac [J].Int J Cancer,2001,91(6):894-9.
[23] Liu XH,Kirschenbuam A,Yao S,et al.Up-regulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell lines [J].Clin Exp Metastasis 1999,17(8):687-94.
[24] Cianchi F,Cortesini C,Bechi P,et al.Up-regulation of cyclooxygenase 2 gene expression correlates with rumor angiogenesis in human colorectal cancer [J].Gastroenterology 2001,121(6):1339-47.
[25] Tsujii M,Kawano S,Dubois RN.Cyclooxygenase-2 expression in human colon cancer cells increase metastatic potential [J].Proc Natl Acad Sci USA,1997,94(7):3336-3340.
[26] Yamamoto S,Konishi I,Mandai M,et al.Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasm:correlation with chinicopathology and patient survival,and analysis of serum VEGF[J].Br J Cancer,1997,76(9):1221-7.
[27] Murata H,Kawano S,Tsuji S,et al.Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma[J].Am J Gastroenterol,1999,94:451-5.
[28] Li G,Yang T,Yan J.Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells [J].Biochem Biophys Res Commun,2002,299(5):886-90.
[29] Yamauchi T,Watanabe M,Kubota T,et al.Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer [J].Dis Colon Rectum,2002,45(1 ):98-103.
[30] Hull MA,Fenwick SW,Chapple KS,et al.Cyclooxygenase-2expression in colorectal cancer liver metastases [J].Clin Exp Metastasis,2000,18(1):21-7.